Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine and CAPOX in Metastatic Colorectal Cancer
NCT01193517Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2010
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in metastatic colorectal cancer (mCRC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2010; status: completed.
02
Drugs
azacitidine
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01193517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193517.